L
LENZ Therapeutics, Inc. (LENZ)
8.40
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
8.40
0.00 (0.00%)
LENZ Therapeutics, Inc. AQShda ko'rishni yaxshilashga qaratilgan terapiyalarni ishlab chiqish va tijoratlashtirishga ixtisoslashgan tijorat farmatsevtika kompaniyasi sifatida faoliyat yuritadi. Uning mahsulot nomzodlari orasida kattalardagi presbiopiyani davolash uchun VIZZ va LNZ101 mavjud. LENZ Therapeutics, Inc. ilgari Presbyopia Therapies, Inc. nomi bilan tanilgan va 2021 yil iyun oyida LENZ Therapeutics, Inc. deb nomini o'zgartirgan. Kompaniya 2013 yilda tashkil etilgan va Kaliforniyaning Solana Beach shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Kris Gambelin | Senior Vice President of Regulatory & Clincal Operations |
| Mr. Daniel R. Chevallard CPA | Chief Financial Officer |
| Mr. David Choromanski | Vice President of Marketing |
| Mr. Domenick Porfidia | Vice President of Sales |
| Mr. Evert B. Schimmelpennink | President, CEO, Secretary & Director |
| Mr. James W. McCollum | Co-Founder & Director |
| Mr. Marc G. Odrich M.D. | Chief Medical Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-01-07 | 8-K | lenz-20260107.htm |
| 2025-12-12 | 8-K | lenz-20251212.htm |
| 2025-11-05 | 10-Q | lenz-20250930.htm |
| 2025-10-08 | 8-K | lenz-20251008.htm |
| 2025-09-30 | 8-K | lenz-20250930.htm |
| 2025-07-31 | 8-K | lenz-20250731.htm |
| 2025-07-30 | 8-K | lenz-20250730.htm |
| 2025-06-10 | 8-K | lenz-20250610.htm |
| 2025-05-07 | 10-Q | lenz-20250331.htm |
| 2025-04-28 | ARS | d742127dars.pdf |
| Mr. Shawn Olsson |
| Chief Commercial Officer |
| Ms. Melissa Rosness | Senior Vice President of Manufacturing Operations |